A blog by MIT that details the issues between drug creation within AI models and regulations in the US. This highlights the problems that AI are currently in drug regulations – especially concerning creating new drugs so rapidly that it might have a negative impact on reducing harmful side effects. 

Link: What to do about AI in health? 

Why is this important?  

It highlights areas of regulation and policy that AI are affecting.  

Source Credibility: MIT is a university with leading research in the area of AI